Par Pharmaceutical: High-Quality, Cost-Effective Generic Products

Par Pharmaceutical, based in Chestnut Ridge, New York, develops, manufactures and markets safe, innovative and cost-effective generic pharmaceutical products that help improve patient quality of life. Par’s differentiated portfolio includes alternative dosage products as well as many products in difficult-to-manufacture areas. Additionally, the Par portfolio includes both branded and generic sterile injectable products. The Company is advancing a research and development (R&D) pipeline of >300 potential new products. Par Pharmaceutical is an operating company of Endo International plc, a global specialty pharmaceutical company focused on improving patients' lives while creating shareholder value.

The recent combination of the Qualitest and Par businesses (known collectively as Par Pharmaceutical) expands Endo’s generics business to a top five industry leader.

Learn More at

About UsEndo Pharmaceuticals - Product Pipeline

Learn more about Par Pharmaceutical’s history, mission, facilities and commitment to compliance and quality.

Learn more

Current Market Products

Endo Pharmaceuticals - Market Products

Our generic-drug portfolio consists of numerous products across a wide range of therapeutic areas that are the therapeutic equivalent of the brand-name pharmaceuticals.

Learn more